34 results
6-K
EX-99.1
RDHL
Redhill Biopharma Ltd.
17 Aug 22
RedHill Biopharma Announces EU Orphan Drug Designation for RHB-204 for NTM Infections
8:08am
Workshop Report Annals of the American Thoracic Society 2016; S379-84.
11 Movantik® (naloxegol) is indicated for opioid-induced constipation (OIC). Full
FWP
3m7r0jdm
1 Mar 21
Free writing prospectus
5:02pm
6-K
EX-1
xa39czva 6x
18 Feb 21
RedHill Biopharma Strengthens Partnership with Cosmo
7:00am
FWP
8hrcd
11 Jan 21
Free writing prospectus
4:54pm
6-K
EX-1
hnr m6muz5pcef1q
6 Jan 21
RedHill Biopharma's RHB-204 Granted FDA Fast Track
7:00am
6-K
EX-1
f9x0w
20 Nov 20
Current report (foreign)
8:00am
6-K
EX-1
7ujpl3 ti
14 Oct 20
Current report (foreign)
11:00am
6-K
EX-1
aj0o0n3sip
31 Jul 20
Current report (foreign)
8:38am
6-K
EX-99.1
sn3fge0s dxi3
29 Oct 18
Current report (foreign)
7:00am
6-K
EX-99.1
7du 7xkv7a8k9b
30 May 18
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
8:01am
6-K
EX-99.1
tn4nc lkjhb91ulj
20 Oct 17
RedHill Biopharma Receives FDA Orphan Drug Designation for MESUPRON for Pancreatic Cancer
12:00am
6-K
EX-99.1
pzxfmzft849o4swirv3
6 Oct 16
RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for Success in Q2/2017
12:00am